1. Home
  2. CSPI vs VRCA Comparison

CSPI vs VRCA Comparison

Compare CSPI & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSP Inc.

CSPI

CSP Inc.

N/A

Current Price

$9.99

Market Cap

107.1M

Sector

Technology

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

N/A

Current Price

$7.00

Market Cap

87.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSPI
VRCA
Founded
1968
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.1M
87.5M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
CSPI
VRCA
Price
$9.99
$7.00
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
8.1K
69.3K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
1.15%
N/A
EPS Growth
75.00
N/A
EPS
0.01
N/A
Revenue
$58,730,000.00
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
$944.21
N/A
Revenue Growth
6.36
370.22
52 Week Low
$7.55
$0.39
52 Week High
$16.50
$9.82

Technical Indicators

Market Signals
Indicator
CSPI
VRCA
Relative Strength Index (RSI) 51.93 62.66
Support Level $7.99 $5.16
Resistance Level $12.78 $7.35
Average True Range (ATR) 0.57 0.44
MACD -0.03 0.05
Stochastic Oscillator 31.40 77.19

Price Performance

Historical Comparison
CSPI
VRCA

About CSPI CSP Inc.

CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Share on Social Networks: